INSIG1 and metabolic dysfunction-associated steatotic liver disease: All of these upstream regulators have been shown to be involved in NASH progression, lending weight to the hypothesis that Insig1 downregulation might directly/indirectly lead to a pleiotropic protective set of mechanisms that attenuate inflammation and liver damage in NAFLD [41,42].